Keymed Biosciences Inc. (2162.HK)

HKD 33.0

(-1.93%)

Gross Profit Summary of Keymed Biosciences Inc.

  • Keymed Biosciences Inc.'s latest annual gross profit in 2023 was 317.21 Million CNY , up 225.42% from previous year.
  • Keymed Biosciences Inc.'s latest quarterly gross profit in 2024 Q2 was 25.47 Million CNY , down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a annual gross profit of 97.47 Million CNY in annual gross profit 2022, up 4.74% from previous year.
  • Keymed Biosciences Inc. reported a annual gross profit of 93.06 Million CNY in annual gross profit 2021, down 0.0% from previous year.
  • Keymed Biosciences Inc. reported a quarterly gross profit of 25.47 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Keymed Biosciences Inc. reported a quarterly gross profit of 2.55 Million CNY for 2023 Q3, down -98.36% from previous quarter.

Annual Gross Profit Chart of Keymed Biosciences Inc. (2023 - 2019)

Historical Annual Gross Profit of Keymed Biosciences Inc. (2023 - 2019)

Year Gross Profit Gross Profit Growth
2023 317.21 Million CNY 225.42%
2022 97.47 Million CNY 4.74%
2021 93.06 Million CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%

Peer Gross Profit Comparison of Keymed Biosciences Inc.

Name Gross Profit Gross Profit Difference
Uni-Bio Science Group Limited 392.81 Million HKD 19.246%
CK Life Sciences Int'l., (Holdings) Inc. 947.7 Million HKD 66.528%